Premium
P3‐123: HUMAN AUTOANTIBODIES TO TAU PROTEIN: HOW SPECIFIC ARE THEY?
Author(s) -
Ricny Jan,
Kolarova Michala,
Bartos Ales,
Ripova Daniela
Publication year - 2014
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2014.05.1212
Subject(s) - antibody , autoantibody , titer , serial dilution , tau protein , chemistry , bovine serum albumin , recombinant dna , pathological , disease , microbiology and biotechnology , immunology , medicine , biology , biochemistry , alzheimer's disease , pathology , alternative medicine , gene
Age baseline 70.0065.01 69.9364.42 0.06 0.955 Gender female 23 (63.89) 24 (80.00) 2.07 0.180 Education 6.464.8 3.964.3 2.18 0.033 Follow up duration 5.3660.68 5.2360.56 0.82 0.417 HTN 21 (58.33) 17 (56.67) 0.02 0.545 DM 2 (5.56) 5 (16.67) 2.13 0.231 BMI (kg/m) Baseline 25.6963.61 25.3964.61 0.26 0.794 Follow up 25.8763.81 25.8364.61 0.04 0.972 KSGDS Baseline 5.1464.07 6.3864.03 -1.23 0.224 Follow up 5.9765.12 8.4366.74 -1.69 0.097 y T-test or 2 test were tested. All values are mean6SD (continuous variables) or frequencies (N,%)(categorical variables). Abbreviation: NCI1⁄4not cognitive impaired subject, HTN1⁄4Hypertension, DM1⁄4Diabetes Mellitus, BMI1⁄4Body Mass Index, KSGDS1⁄4 Short Form Geriatric Depression Scale Korean version.